US Patent Issued to ALTEOGEN on July 29 for "Hyaluronidase variants and pharmaceutical composition comprising the same" (South Korean Inventors)

ALEXANDRIA, Va., July 30 -- United States Patent no. 12,371,683, issued on July 29, was assigned to ALTEOGEN Inc. (Daejeon, South Korea).

"Hyaluronidase variants and pharmaceutical composition comprising the same" was invented by Soon Jae Park (Daejeon, South Korea), Hye-Shin Chung (Daejeon, South Korea), Seung Joo Lee (Daejeon, South Korea), Sun-Ah You (Daejeon, South Korea), Hyung-Nam Song (Daejeon, South Korea) and Chang Woo Lee (Daejeon, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention is related to the field of protein engineering technology which increases the enzymatic activity and thermal stability of human hyaluronidase which is an enzyme that hydrolyzes hyaluronic ac...